Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jonghan Yu"'
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: It is important to identify factors predicting successful ovarian protection using gonadotropin-releasing hormone (GnRH) agonists during chemotherapy. However, only a few studies have prospectively assessed this issue in young breast canc
Externí odkaz:
https://doaj.org/article/0007cd9941d74257bdc662724a7c9dd3
Autor:
Seok Won Kim, Sung Mi Jung, Se Kyung Lee, Jeong Eon Lee, Jonghan Yu, Jinsun Woo, Jai Min Ryu, Byung Joo Chae, Seok Jin Nam, Hee Jun Choi
Publikováno v:
European Journal of Surgical Oncology. 47:232-239
Background The aim of this study was to examine the accuracy of radiologic complete response (rCR) in predicting pathologic complete response (pCR), and determine whether rCR is a predictor of favorable survival outcomes. Materials and methods We ret
Autor:
Gyungyub Gong, Byung Hee Jeon, Kyoung-Yeon Kim, Sei Hyun Ahn, YongNam Kim, Hee Jin Lee, Cham Han Lee, Il Yong Chung, Sung-chan Gwark, Mi Young Choi, Myoung Shin Kim, Ji Yeon Park, Jong Won Lee, Jisun Kim, Sae Byul Lee, Young Hun Kim, Kyung Hae Jung, Jin-Hee Ahn, Nak-Jung Kwon, Byung Ho Son, Suhwan Chang, Jonghan Yu, Sung Bae Kim, Hee Jeong Kim, Sung Woo Hong, Beom Seok Ko
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
Scientific Reports
Scientific Reports
We evaluated the prognostic implications of the circulating tumor cell (CTC) count in non-metastatic, HER2-negative breast cancer patients who failed to achieve pathologic complete response (pCR) after neoadjuvant chemotherapy (NCT). A total of 173,
Autor:
Hae Hyun Jung, Seok Won Kim, Yeon Hee Park, Kyunghee Park, Ji-Yeon Kim, Jeong Eon Lee, Jonghan Yu, Se Kyung Lee, Seok Jin Nam
Publikováno v:
Cancer Research. 80:P1-10
Introduction: Neoadjuvant chemotherapy (NAC) enables curative surgery and deprives micrometastasis in locally advanced breast cancer (LABC). Indeed, response of NAC, representatives of pathologic complete response (pCR) as well as residual cancer bur
Autor:
Jinsun Woo, Seok Jin Nam, Se Kyung Lee, Byung Noe Bae, Inseok Park, Jeong Eon Lee, Seok Won Kim, Geumhee Gwak, Jonghan Yu, Jai Min Ryu, Byung Joo Chae
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Decision to undergo risk-reducing mastectomy (RRM) needs to consider several factors, including patient’s preference, surgeon’s preference, family history, and genetic predisposition. The aim of this study was to examine whether preoperative diag
Autor:
Jai Min Ryu, Soo Youn Cho, Jonghan Yu, Se Kyung Lee, Jeong Eon Lee, Seok Jin Nam, Jinil Han, Seok Won Kim, Byung Joo Chae, Jee Hyun Ahn, Jun Hee Lee
The GenesWell™ BCT (BCT score) is a recently developed multigene assay that predicts the risk of distant recurrence in patients with hormone receptor-positive (HR+) and HER2 negative (HER2-) early breast cancer (BC). The ability of the assay to pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5be4ebfcdd11b6ffaa032a93ec5dbd7
https://doi.org/10.21203/rs.3.rs-523729/v1
https://doi.org/10.21203/rs.3.rs-523729/v1
Autor:
Jong Won Lee, Jonghan Yu, Ji Yeon Park, Hee Jeong Kim, Suhwan Chang, Mi Young Choi, Byung Ho Son, Young Hun Kim, Sung Woo Hong, Kyung Hae Jung, Kyoung-Yeon Kim, Sei Hyun Ahn, Hee Jin Lee, Jisun Kim, Il Yong Chung, Sung Bae Kim, YongNam Kim, Nak-Jung Kwon, Beom Seok Ko, Sae Byul Lee, Myoung Shin Kim, Jin-Hee Ahn, Cham Han Lee, Byung Hee Jeon, Sung-chan Gwark, Gyungyub Gong
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
We evaluated the prognostic implications of the circulating tumor cell (CTC) count in non-metastatic, HER2-negative breast cancer patients who failed to achieve pathologic complete response (pCR) after neoadjuvant chemotherapy (NCT). A total of 173,
Autor:
Isaac Kim, Jonghan Yu, Seok Won Kim, Se Kyung Lee, Hee Jun Choi, Seok Jin Nam, Jai Min Ryu, Jeong Eon Lee
Publikováno v:
Breast Cancer Research and Treatment. 176:591-596
Many breast cancer patients receive sentinel lymph node biopsy after neoadjuvant chemotherapy (NAC). We evaluated the axillary pathologic complete response (pCR) in relation to achievement of breast pCR. We evaluated 1044 patients who were diagnosed
Autor:
Seok Won Kim, Soo Youn Bae, Se Kyung Lee, Seok Jin Nam, Jonghan Yu, Jeong Eon Lee, Seung Pil Jung
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 34, Iss 12, Pp 663-672 (2018)
Mutations of the p53 gene are the most common genomic alterations associated with triple-negative breast cancer (TNBC) and are reported in 60–88% cases. Despite the high incidence of such mutations, there is no consensus about the clinical applicat
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Background: It is important to identify factors predicting successful ovarian protection using gonadotropin-releasing hormone (GnRH) agonists during chemotherapy. However, only a few studies have prospectively assessed this issue in young breast canc